News | FDA

Top News

Court Stays Rule Requiring Price Disclosures in…

Full Article

July 9, 2019
NPRM To Harmonize FDA Rules with Revised Common…

Full Article

June 3, 2019
Next FDA Head Will Confront Full Agenda of…

Full Article

April 8, 2019
FDA Looks to ‘Tailored Review Framework’ for…

Full Article

April 8, 2019
NCI Director Sharpless To Serve as Acting FDA…

Full Article

March 12, 2019

LATEST HEADLINES

Health Canada Opens Consultation on Distinction…

July 17, 2019
EC Revises Safety Guidance for Products Used in…

July 17, 2019
FDA Proposes Exemptions from eCTD for Some Type III…

July 16, 2019
Improvement Needed in Trial Transparency and Data…

July 15, 2019
FDA Issues Draft Guidance on Development of Hormonal…

July 15, 2019
Viewpoint Contends Researchers Must Better Protect…

July 14, 2019
FDA Revises 20-year-old Guidance on Population…

July 14, 2019
Federal Court Rejects Corrective Advertising Request…

July 14, 2019
Company Pays $1.4 Billion To Resolve Federal…

July 13, 2019
Elements To Include in Live Case Presentation Request

July 11, 2019

Latest FDA Intelligence

OPDP Enforcement Emphasizing Risk Minimization

July 6, 2019
Recent Untitled Letter Offers Blueprint for Handling Risk/Safety…

June 8, 2019
Consumer Education Needed on DTC Ad Info

May 6, 2019
New Era of Drug Promotion Dawns

April 6, 2019
Gottlieb Will Be a Tough Act To Follow

March 11, 2019

Copyright © Thompson FDA, a division of CBIS. All rights reserved.